SCHEMBL25976979

SCHEMBL25976979

Cc1ccccc1-c1cc(-c2cc(-c3c(C)cccc3C)c(C)c[n+]2C)c(C)cc1C

nearest known ligand 0.37

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
▸ MYC P01106 1/20 0.37
▸ DHFR P00374 1/20 0.35
▸ PLA2G7 Q13093 3/20 0.33
▸ HTR7 P34969 2/20 0.31
▸ PDK2 Q15119 1/20 0.31
▸ CA1 P00915 2/20 0.31
▸ CA2 P00918 2/20 0.31
▸ CA9 Q16790 2/20 0.31
▸ CA7 P43166 1/20 0.31
▸ CA12 O43570 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25976978 0.92 PLA2G7 (0.37) DHFRPLA2G7CA1CA2CA9
SCHEMBL25976999 0.92 PDK2 (0.33) DHFRPLA2G7PDK2
SCHEMBL25976682 0.87 MYC (0.36) MYCDHFRHTR7
SCHEMBL25976977 0.85 ESR2 (0.36) DHFRPLA2G7HTR7CA1CA2
SCHEMBL25976656 0.85 ESR2 (0.36) DHFRPLA2G7HTR7CA1CA2
SCHEMBL25976980 0.85 ELANE (0.34) DHFRPLA2G7
SCHEMBL25983202 0.85 CD274 (0.34) PLA2G7PDK2CA1CA2CA9
SCHEMBL25976865 0.84 PLA2G7 (0.36) DHFRPLA2G7CA1CA2CA9
SCHEMBL25976920 0.84 HTR7 (0.39) MYCHTR7PDK2CA1CA2
SCHEMBL25976919 0.79 AR (0.38) PLA2G7HTR7PDK2CA1CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230331758-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES UNIVERSAL DISPLAY CORPORATION (US) 2023-10-19 — — US disclosed
US-11725021-B2 Organic electroluminescent materials and devices UNIVERSAL DISPLAY CORPORATION (US) 2023-08-15 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11725021-B2 Organic electroluminescent materials and devices NCL, OCIAD2, OCIAD1 MYC 1446/4885DHFR 4423/4885PLA2G7 3328/4885
US-20230331758-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES NCL, OCIAD2, OCIAD1 MYC 1446/4885DHFR 4423/4885PLA2G7 3328/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback